You just read:

Celator® Pharmaceuticals Announces Upcoming Phase 3 Data Presentations at American Society of Clinical Oncology (ASCO) and European Hematology Association (EHA)

News provided by

Celator Pharmaceuticals, Inc.

May 19, 2016, 16:05 ET